The Albany Gazette - Medical Care Technologies Inc. (OTCID:MDCE) Advances Melanoma Scan Beta With Next-Week Results Posting

NYSE - LSE

RBGPF	0%	70.49	$
CMSC	0.15%	19.85	$
BCE	-0.63%	20.54	$
BP	-0.61%	47.59	$
BTI	-1.66%	60.9	$
GSK	-0.88%	48.7	$
NGG	-1.92%	82.83	$
RELX	-2.69%	39.4	$
RIO	-1.36%	81.62	$
CMSD	-0.15%	19.86	$
BCC	-0.25%	74.81	$
VOD	-0.19%	15.62	$
AZN	-1.47%	183.88	$
RYCEF	-0.24%	16.92	$
JRI	0.88%	11.36	$

Medical Care Technologies Inc. (OTCID:MDCE) Advances Melanoma Scan Beta With Next-Week Results Posting

BOULEVARD 20.10.2026

Medical Care Technologies Inc. (OTCID:MDCE) Advances Melanoma Scan Beta With Next-Week Results Posting

Larger Human-Submitted Dataset Now Ready for Public Technical Update as Testing Continues

Text size:

MESA, AZ / ACCESS Newswire / October 20, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today announced that updated internal evaluation results for MDCE Melanoma Scan Beta will be posted on the Company's corporate website next week.

The results will be available at https://www.medicalcaretechnologies.com.

This update follows the Company's October 8 announcement that volunteer intake remained open and that a next-round evaluation would be published. That sequence now reaches the reporting step. The posting will cover the same three technical layers already under review:

Image intake and quality scoring - whether new user photographs can be received and separated into usable and held-out samples
Body-map registration - whether images can be placed on the interactive body map so the same skin area can be found again
Change-over-time comparison - whether successive images of a mapped area can be organized for visual review

The program has already moved through volunteer intake (September 4), receipt of the first human-submitted datasets (September 16), the start of internal review (September 23), and first-pass results (September 29). The first pass showed that real-world user photographs could move through the three layers. The next-week posting is the expanded readout on the larger set of submissions collected since then.

Until the volunteer phase, model work centered on public dermatology archives, including HAM10000, ISIC Archive collections, and TCIA melanoma cohorts. Human-submitted images add lighting, device type, distance, angle, compression, and everyday image quality that those archives do not fully capture. The upcoming results reflect continued testing against that real-world variability.

"The first pass showed the workflow can run on photographs people actually take," said Marshall Perkins, CEO of Medical Care Technologies. "Next week we post the next readout on the expanded set. Intake remains open because a wider test set strengthens the evaluation."

MDCE Melanoma Scan Beta is being developed as an AI-assisted imaging and body-map monitoring application intended to help users catalog visible skin images and review the same mapped area across sessions. The platform remains in beta-stage development. It has not received regulatory clearance and is not intended to treat, cure, or prevent any disease or medical condition. It is not a substitute for professional medical advice, screening, or evaluation by a qualified healthcare provider.

About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTCID: MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. Visit: https://www.medicalcaretechnologies.com

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding planned publication of evaluation updates. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.

Contact Information:
Medical Care Technologies Inc.
1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204
Phone: +1 (480) 645-0750
Email: [email protected]
Website: https://www.medicalcaretechnologies.com

SOURCE: Medical Care Technologies Inc.

View the original press release on ACCESS Newswire

(M.Scott--TAG)

Featured

Julia Stiles and Ezra Sosa Share Emotional Farewell After 'DWTS' Elimination

Julia Stiles and her Dancing With the Stars partner, Ezra Sosa, shared tearful interviews after being eliminated during "Disney Night." The pair reflected on their time together, with Sosa praising Stiles' influence on his personal growth and Stiles citing newfound confidence from the competition.

John Schneider Admits Owes Millions in 'Dukes of Hazzard' Divorce Battle

'Dukes of Hazzard' actor John Schneider has formally acknowledged a debt of roughly $3.7 million in back spousal support to his ex-wife, Elvira Schneider, marking a shift in their ongoing divorce proceedings. While admitting the financial obligation, Schneider is contesting a court order that would divert half of his Social Security benefits to satisfy the arrears.

Philippine Authorities Report Progress in Thomas Markle Sr. Child Pornography Probe

Philippine authorities have confirmed that their investigation into Thomas Markle Sr.’s alleged possession of child pornography is progressing, with Acting Director Pmgen Wilson Casueta stating the probe is moving in the "right direction." The inquiry follows allegations by Markle’s son, Thomas Jr., who reported finding graphic materials at his father’s Cebu City residence.

Doha hotel and Carolina Herrera launch fragrance-inspired afternoon tea

Waldorf Astoria Doha Lusail announces an exclusive collaboration with Carolina Herrera, bringing together the world of luxury fragrance and the art of afternoon tea in a distinctive experience at Peacock Alley. Inspired by the best-sellers from the Herrera Confidential collection, Cedar Chic, and Stallion Leather Suede, and the novelty Peccato Nobile, the limited-edition afternoon tea brings the character of each fragrance to life through an elegant collection of sweet and savory creations.